Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?


Subcutaneous allergen immunotherapy (SCIT) clearly benefits appropriately selected patients with allergic rhinitis, asthma and anaphylaxis to stinging insects. Since inception of SCIT, systemic allergic reactions (SRs) and severe anaphylaxis have been risk management challenges facing the practicing allergist. Recently it has estimated that 14% of reported… (More)
DOI: 10.1016/j.jaip.2016.04.007


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics